More than 100+ partners trust us
Distribution of
funds by sector:
Biotechnology and pharmaceuticals
Clean energy and eco-technologies
IT startups and software
Automation and robotics
What companies we invest in:
the last year
A biotech company that has revolutionized vaccine technology.
the last year
a leader in electric vehicles and clean energy with continuous innovation.
the last year
the world leader in robotic business process automation.
the last year
a company offering efficient energy solutions for solar power plants.
How HID Fund investing is changing the world
By supporting startups and innovation, HID Fund accelerates the development of medical technologies, environmental solutions and industrial automation. We help create a healthier, greener, and more technologically advanced future, enabling sustainable growth and improved quality of life.
Participation in grants and international programs
HID Fund finances international research grants, attracts leading experts from different countries and supports the implementation of innovations in clinics, research centers and industrial companies. We create an ecosystem for sharing knowledge and developing breakthrough technologies on a global level.
HID Fund's most successful investments in technology startups
The company has developed a commercially available quantum processor that has significantly accelerated the solution of the most complex computational problems in science, finance and medicine. In 3 years, QuantumLeap has shown a capitalization growth of more than 350%, and its technologies are already being implemented in the world's leading research centers, opening up a new level of computing power.
The startup focused on developing biosynthetic materials to replace plastic and other environmentally harmful substances. Their innovations have contributed to the reduction of environmental pollution and have been massively applied in the production of packaging and textiles. Over the last 3 years, EcoSynth's capitalization has grown more than 270 times and the company actively cooperates with international environmental initiatives.
The company has created safe and effective interfaces to connect the human brain with computers, opening new possibilities for rehabilitation after injuries and neurodegenerative diseases. In 3 years, NeuraLink Health has demonstrated a 320% growth in the value of investments, and their developments have become an international benchmark in the field of neurotechnology.
Our investment helped bring to market the BioSense portable diagnostic device, which can quickly and accurately detect a wide range of diseases right at the patient's doorstep, without the need for expensive laboratory tests. This made diagnostics more accessible, especially in remote regions, and reduced the time to start treatment. The return on investment amounted to +210%.
HID Fund supported GeneTailor, a startup that has developed a system for analyzing genomic data using artificial intelligence to create individualized treatment plans. This technology has made it possible to improve the effectiveness of treatment of chronic and rare diseases, making therapy more accurate and less toxic. The investment yielded more than +230%.
LifePrint is a startup developing 3D bioprinting technologies for tissues and organs for transplantation. Thanks to our support, the project was able to bring the first prototypes of printed tissues to the market, which opens up new opportunities for saving the lives of patients with organ failure and reduces the shortage of donor organs. The return on investment exceeded +190%.
Invest like a system - Earn like a fund.
